Mink TherapeuticsINKT
13F holders, Q1 2025 (March 31)1holders −22
0new positions
8sold out
$8.64avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Mink Therapeutics Inc. (INKT) in their 13F filings, down 22 from Q4 2024. 0 opened new positions and 8 sold out. The largest holder was Longbow Finance SA ($144K).
- Company
- Mink Therapeutics Inc.
- CUSIP
- 603693102
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 8 | $140K |
All 13F filers, Q4 2024 → Q1 2025: 350,189 shares sold, net −350,189 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Longbow Finance SA | 0.02% | Reduce -90.0% | 16,667 | $144K |
"% of holder's portfolio" is INKT's weight in each manager's 13F, not the share of Mink Therapeutics Inc. the manager owns.